Psychedelics like psilocybin and LSD act as partial agonists of serotonin 5-HT2A receptors, potentially modulating neural pathways involved in pain perception and neurovascular inflammation associated with cluster headaches. These compounds appear to interrupt the pathological neurological patterns underlying cluster headache cycles through central nervous system receptor interactions, with some patients reporting significant reduction in headache frequency and intensity after controlled therapeutic use.